Aspect Medical Systems & Boston Scientific Form Strategic Alliance to Develop Brain Monitoring Technology for Diagnosing and Treating Depression & Alzheimer's Disease; Conference Call Scheduled for Today.NEWTON, Mass. -- Aspect Medical Systems, Inc. (Nasdaq: ASPM ASPM Abnormal Spindle-Like Microcephaly Associated ASPM Asociación del Secretariado Profesional de Madrid (Spanish: Association of the Professional Secretaryship of Madrid) ASPM Armed Services Procurement Regulation Manual ) and Boston Scientific (NYSE NYSE See: New York Stock Exchange : BSX BSX Bermuda Stock Exchange BSX Bandai Satellaview-X BSX Bicycle Super-X (Cross) ) have announced the formation of a strategic alliance to develop brain monitoring technology for diagnosing and treating depression and Alzheimer's disease Alzheimer's disease (ăls`hī'mərz, ôls–), degenerative disease of nerve cells in the cerebral cortex that leads to atrophy of the brain and senile dementia. . Today, beginning at 12:00pm EDT EDT abbr. Eastern Daylight Time EDT Eastern Daylight Time EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York EDT , the Companies will host a conference call and live webcast for all interested parties, including financial analysts, portfolio managers, individual investors and members of the press. To participate in the call, please dial 1-800-810-0924 (domestic), 1-913-981-4900 (international), or you may access the webcast at http://www.aspectmedical.com on the Investor page, or at http://ccbn.com. Telephone replays will be available by dialing 1-888-203-1112 (domestic), or 1-719-457-0820 (international), access code 1614513. The webcast replay will be available from May 23, 2005, 3:00pm EDT until May 30, 2005. About Boston Scientific Corporation Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com. About Aspect Medical Systems, Inc. Aspect Medical Systems, Inc. (Nasdaq: ASPM) is a global market leader in brain monitoring technology. Aspect's BIS technology directly measures the effects of anesthetics Anesthetics Drugs or methodologies used to make a body area free of sensation or pain. Mentioned in: Appendectomy and sedatives on the brain. To date, BIS technology has been used to assess more than 11.3 million patients and has been the subject of approximately 1,800 published articles and abstracts. BIS technology is installed in approximately 38 percent of all domestic operating rooms and is available in more than 160 countries. Aspect has OEM (Original Equipment Manufacturer) The rebranding of equipment and selling it. The term initially referred to the company that made the products (the "original" manufacturer), but eventually became widely used to refer to the organization that buys the products and agreements with seven leading manufacturers of patient monitoring systems. The Company is also investigating how other methods of analyzing brain waves may aid in the diagnosis and management of neurological diseases, including depression and Alzheimer's disease. For more information, visit Aspect's web site at http://www.aspectmedical.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion